Titlebook: Advances in Research on Neurodegeneration; P. Riederer,D. B. Calne,M. B. H. Youdim Conference proceedings 2000 Springer-Verlag Wien 2000 A

威風(fēng)

書目名稱Advances in Research on Neurodegeneration影響因子(影響力)




書目名稱Advances in Research on Neurodegeneration影響因子(影響力)學(xué)科排名




書目名稱Advances in Research on Neurodegeneration網(wǎng)絡(luò)公開度




書目名稱Advances in Research on Neurodegeneration網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Advances in Research on Neurodegeneration被引頻次




書目名稱Advances in Research on Neurodegeneration被引頻次學(xué)科排名




書目名稱Advances in Research on Neurodegeneration年度引用




書目名稱Advances in Research on Neurodegeneration年度引用學(xué)科排名




書目名稱Advances in Research on Neurodegeneration讀者反饋




書目名稱Advances in Research on Neurodegeneration讀者反饋學(xué)科排名

languor

inquisitive

Hybrid Arrays for Chemical Sensingegenerative diseases. These including the parkinsonian syndromes, the trinucleotide repeat disorders and the dementia syndromes. The increased brain iron is confined to those brain regions most affected by the degeneration characteristic of the particular disorder and is suggested to stimulate cell

Admonish

Congestion

ablate

Benjamin P. Hay,Vyacheslav S. Bryantsevenesis of PD is supported by the demonstration of the high concordance in twins, increased risk among relatives of PD patients in case control and family studies, and the existence of familial PD and parkinsonism based on single gene defects. Recently, several genes have been mapped and/or identifie

憎惡

Radislav A. Potyrailo,Vladimir M. Mirskyal dopamine neurodegeneration and its protection with R-apomorphine. Both MPTP (N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) and R-apomorphine (R-APO) induced alterations in specific patterns of gene expression. MPTP altered the expression of 49 different genes involved in oxidative stress (oxidati

Monocle

insolence

女歌星

Caleb Lareau,Divy Kangeyan,Martin J. AryeeMAO)-B inhibitor, rasagiline (N-propargyl-(1R)aminoindan), possessing both cholinesterase (ChE) and MAO-inhibitory activity. In doses of 35-100 μmoles/kg administered orally to rats, it inhibits ChE by 25-40% and antagonises scopolamine-induced impairments in spatial memory. After daily administrati